by Sue Robbins | Oct 12, 2023 | Miscellaneous
Read more here
by Sue Robbins | Jul 2, 2023 | Migraine
Read more here
by Sue Robbins | Jan 27, 2020 | Migraine
Treatment with the orally administered, small-molecule calcitonin gene-related peptide receptor antagonist ubrogepant in patients with acute migraine has been associated with freedom from pain and the absence of the patient-determined most troublesome symptom compared...
by Sue Robbins | May 6, 2019 | Migraine
Read more here.